Baird Medical Investment Holdings (BDMDW) Equity Ratio (2023 - 2025)

Baird Medical Investment Holdings' quarterly Equity Ratio came in at 0.45 in Q4 2025, down 11.94% year-on-year from 0.51 in Q4 2024, and down 11.94% quarter-over-quarter from 0.51 in Q4 2024.

Baird Medical Investment Holdings has reported Equity Ratio for 3 years, with the latest figure at 0.45 in Q4 2025.

  • For the quarter ending Q4 2025, Equity Ratio fell 11.94% year-over-year to 0.45; the trailing twelve-month figure through Dec 2025 stood at 0.45 (down 11.94% YoY), and the FY2025 full-year result was 0.45, down 11.94% from the prior year.
  • Equity Ratio for Q4 2025 stood at 0.45, down from 0.51 in the prior quarter.
  • The five-year high for Equity Ratio was 0.63 in Q4 2023, with the low at 0.45 in Q4 2025.
  • Average Equity Ratio over 3 years is 0.53, with a median of 0.51 recorded in 2024.
  • Year-over-year, Equity Ratio declined 19.21% in 2024 and declined 11.94% in 2025.
  • Tracing BDMDW's Equity Ratio over 3 years: stood at 0.63 in 2023, then decreased by 19.21% to 0.51 in 2024, then dropped by 11.94% to 0.45 in 2025.
  • The last three Equity Ratio figures came in at 0.45 (Q4 2025), 0.51 (Q4 2024), and 0.63 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 0.47
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 0.50
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 0.54
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 0.59
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.78
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 0.45
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 0.29
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 0.67
10 Baird Medical Investment Holdings - - - 0.45

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 0.45
Dec 31, 2024 0.51
Dec 31, 2023 0.63